ENTITY
Bio-Thera Solutions Ltd

Bio-Thera Solutions Ltd (688177 CH)

55
Analysis
Health Care • China
Bio-Thera Solutions, Ltd. researches and develops innovative and biosimilar therapeutics. The Company produces innovative monoclonal antibodies, adalimumab biosimilars, innovative drugs, and other related products. Bio-Thera Solutions markets its products throughout China.
more
Exchange Announcement • 04 Mar 2021 23:06

Biotech'S Announcement On The Company'S 2021 Remuneration Plan For Directors, Supervisors And Senior Management (百奥泰关于公司2021年度董事、监事和高级管理人员薪酬方案的公告)

Exchange Announcement • 08 Feb 2021 20:12

Biotech'S Announcement On The Termination Of The Bat8001 Clinical Trial (百奥泰关于终止Bat8001临床试验的公告)

Exchange Announcement • 08 Feb 2021 15:49

Biotech Voluntarily Disclosed An Informative Announcement On The Progress Of Bat8001 Clinical Trials (百奥泰自愿披露关于Bat8001临床试验进展的提示性公告)

Exchange Announcement • 07 Feb 2021 16:29

Announcement Of Biotech Voluntary Disclosure On Obtaining Clinical Trial Approval Notice For Recchiumab (Bat2306) Injection (百奥泰自愿披露关于司库奇尤单抗 [Bat2306] 注射液获得临床试验批准通知书的公告)

Exchange Announcement • 05 Feb 2021 17:40

China International Capital Corporation'S Verification Opinion On The Listing And Circulation Of Certain Restricted Shares Of Biotech Biopharmaceutical Co., Ltd. (中国国际金融股份有限公司关于百奥泰生物制药股份有限公司首次公开发行部分限售股上市流通的核查意见)

x